Skip to content
The Policy VaultThe Policy Vault

brand Celebrex capsulesMedica

any FDA-approved indication

Preferred products

  • generic celecoxib capsules

Initial criteria

  • Patient meets one of the following: Patient has tried two Step 1 Products (oral NSAIDs) either as prescription products or as over-the-counter (OTC) products at prescription-strength doses, for the current condition; OR is currently taking chronic systemic corticosteroid therapy (e.g., prednisone), warfarin, clopidogrel, prasugrel, Brilinta (ticagrelor tablets), Xarelto (rivaroxaban tablets and oral suspension), Pradaxa (dabigatran capsules), Eliquis (apixaban tablets), Savaysa (edoxaban tablets), chronic aspirin therapy, fondaparinux injection, or a low molecular weight heparin product (i.e., enoxaparin injection, Fragmin [dalteparin injection]); OR has reduced platelet counts or other coagulation disorders; OR is > 75 years of age and is using celecoxib for a chronic condition; OR has had a documented upper gastrointestinal bleed from a duodenal or gastric ulcer; AND
  • Patient has tried the Step 2 Product (generic celecoxib)

Approval duration

1 year